SiRNA-mediated silence of protease-activated receptor-1 minimizes ischemic injury of cerebral cortex through HSP70 and MAP2

Journal of the Neurological Sciences

Volumn 320, Issue 1-2, 2012, Pages 6-11

  Zhang, Jun ^a   Wang, Ying ^a   Zhu, Ping ^b   Wang, Xudong ^a   Lv, Manhua ^a   Feng, Honglin ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Harbin Red Cross Central Hospital   (China)

Author keywords

Cerebral ischemia; Protease activated receptor 1; RNA interference

Indexed keywords

HEAT SHOCK PROTEIN 70; LENTIVIRUS VECTOR; MICROTUBULE ASSOCIATED PROTEIN 2; PROTEINASE ACTIVATED RECEPTOR 1; SMALL INTERFERING RNA;

ANIMAL TISSUE; ARTICLE; BRAIN CELL; BRAIN INFARCTION SIZE; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; RAT; RNA INTERFERENCE; STROKE; WESTERN BLOTTING;

ANIMALS; BRAIN ISCHEMIA; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; GENETIC VECTORS; HSP70 HEAT-SHOCK PROTEINS; INJECTIONS, INTRAVENTRICULAR; LENTIVIRUS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR; RECEPTOR, PAR-1; RNA INTERFERENCE; RNA, SMALL INTERFERING; UP-REGULATION;

EID: 84864626355     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2012.05.040     Document Type: Article

References (43)

1. M. Paciaroni, G. Agnelli, S. Micheli, and V. Caso Efficacy and safety of anticoagulant treatment in acute cardioembolic stroke: a meta-analysis of randomized controlled trials Stroke 38 2007 423 430
2. C.S. Kidwell, L. Latour, J.L. Saver, J.R. Alger, S. Starkman, and G. Duckwiler Thrombolytic toxicity: blood brain barrier disruption in human ischemic stroke Cerebrovasc Dis 25 2008 338 343
3. P.A. Lapchak A critical assessment of edaravone acute ischemic stroke efficacy trials: is edaravone an effective neuroprotective therapy? Expert Opin Pharmacother 11 2010 1753 1763
4. C. Leon-Jimenez, E. Chiquete, C. Cantu, M.J. Miramontes-Saldana, M.A. Andrade-Ramos, and J.L. Ruiz-Sandoval Citicoline for acute ischemic stroke in Mexican hospitals: a retrospective postmarketing analysis Methods Find Exp Clin Pharmacol 32 2010 325 330
5. M. Paciaroni, G. Agnelli, V. Caso, M. Venti, A. Alberti, and P. Milia Prior use of antithrombotic agents and neurological functional outcome at discharge in patients with ischemic stroke J Thromb Haemost 4 2006 1957 1961
6. S.R. Coughlin Thrombin signalling and protease-activated receptors Nature 407 2000 258 264
7. M. Holinstat, A.M. Preininger, S.B. Milne, W.J. Hudson, H.A. Brown, and H.E. Hamm Irreversible platelet activation requires protease-activated receptor 1-mediated signaling to phosphatidylinositol phosphates Mol Pharmacol 76 2009 301 313
8. H. Andersen, D.L. Greenberg, K. Fujikawa, W. Xu, D.W. Chung, and E.W. Davie Protease-activated receptor 1 is the primary mediator of thrombin-stimulated platelet procoagulant activity Proc Natl Acad Sci U S A 96 1999 11189 11193
9. F. Striggow, M. Riek-Burchardt, A. Kiesel, W. Schmidt, P. Henrich-Noack, and J. Breder Four different types of protease-activated receptors are widely expressed in the brain and are up-regulated in hippocampus by severe ischemia Eur J Neurosci 14 2001 595 608
10. 2 +]i-inducing protease-activated receptors (par-1 and par-2) in rat astrocytes and c6 glioma cells Neuroscience 86 1998 597 609
11. E. Sokolova, and G. Reiser Prothrombin/thrombin and the thrombin receptors par-1 and par-4 in the brain: localization, expression and participation in neurodegenerative diseases Thromb Haemost 100 2008 576 581
12. T. Rohatgi, F. Sedehizade, K.G. Reymann, and G. Reiser Protease-activated receptors in neuronal development, neurodegeneration, and neuroprotection: thrombin as signaling molecule in the brain Neuroscientist 10 2004 501 512
13. C.E. Junge, T. Sugawara, G. Mannaioni, S. Alagarsamy, P.J. Conn, and D.J. Brat The contribution of protease-activated receptor 1 to neuronal damage caused by transient focal cerebral ischemia Proc Natl Acad Sci U S A 100 2003 13019 13024
14. C.E. Junge, C.J. Lee, K.B. Hubbard, Z. Zhang, J.J. Olson, and J.R. Hepler Protease-activated receptor-1 in human brain: localization and functional expression in astrocytes Exp Neurol 188 2004 94 103
15. C.E. Hamill, G. Mannaioni, P. Lyuboslavsky, A.A. Sastre, and S.F. Traynelis Protease-activated receptor 1-dependent neuronal damage involves NMDA receptor function Exp Neurol 217 2009 136 146
16. E.E. Olson, P. Lyuboslavsky, S.F. Traynelis, and R.J. McKeon Par-1 deficiency protects against neuronal damage and neurologic deficits after unilateral cerebral hypoxia/ischemia J Cereb Blood Flow Metab 24 2004 964 971
17. Y. Tomari, and P.D. Zamore Perspective: machines for RNAi Genes Dev 19 2005 517 529
18. G. Meister Molecular biology. RNA interference in the nucleus Science 321 2008 496 497
19. E. Bernstein, A.A. Candy, S.M. Hammond, and G.J. Hannon Role for a bidentate ribonuclease in the initiation step of RNA interference Nature 409 2001 363 366
20. E. Lund, S. Gottingen, A. Calando, J.E. Dahlberg, and U. Katy Nuclear export of microRNA precursors Science 303 2004 95 98
21. Y. Lee, C. Ahn, J. Han, H. Choi, J. Kim, and J. Yim The nuclear RNase III Drosha initiates microRNA processing Nature 425 2003 415 419
22. G. Hutvagner, J. McLachlan, A.E. Pasquinelli, E. Balint, T. Tuschl, and P.D. Zamore A cellular function for the RNA-interference enzyme dicer in the maturation of the let-7 small temporal RNA Science 293 2001 834 838
23. G.L. Sen, and H.M. Blau A brief history of RNAi: the silence of the genes FASEB J 20 2006 1293 1299
24. S.M. Elbashir, J. Harborth, W. Lendeckel, A. Yalcin, K. Weber, and T. Tuschl Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells Nature 411 2001 494 498
25. Y.S. Lee, K. Nakahara, J.W. Pham, K. Kim, Z. He, and E.J. Sontheimer Distinct roles for drosophila dicer-1 and dicer-2 in the siRNA/miRNA silencing pathways Cell 117 2004 69 81
26. H. Xia, Q. Mao, H.L. Paulson, and B.L. Davidson SiRNA-mediated gene silencing in vitro and in vivo Nat Biotechnol 20 2002 1006 1010
27. A. de Fougerolles, H.P. Vornlocher, J. Maraganore, and J. Lieberman Interfering with disease: a progress report on siRNA-based therapeutics Nat Rev Drug Discov 6 2007 443 453
28. N. Manjunath, and D.M. Dykxhoorn Advances in synthetic siRNA delivery Discov Med 9 2010 418 430
29. H.L. Feng, L. Yan, and L.Y. Cui Effects of repetitive transcranial magnetic stimulation on adenosine triphosphate content and microtubule associated protein-2 expression after cerebral ischemia-reperfusion injury in rat brain Chin Med J (Engl) 121 2008 1307 1312
30. R.G. Giffard, R.Q. Han, J.F. Emery, M. Duan, and J.F. Pittet Regulation of apoptotic and inflammatory cell signaling in cerebral ischemia: the complex roles of heat shock protein 70 Anesthesiology 109 2008 339 348
31. Y. Li, N. Jiang, C. Powers, and M. Chopp Neuronal damage and plasticity identified by microtubule-associated protein 2, growth-associated protein 43, and cyclin d1 immunoreactivity after focal cerebral ischemia in rats Stroke 29 1998 1972 1980 [discussion 1980-1971]
32. J. Liu, P. Schuff-Werner, and M. Steiner Thrombin/thrombin receptor (par-1)-mediated induction of il-8 and VEGF expression in prostate cancer cells Biochem Biophys Res Commun 343 2006 183 189
33. L. Qiao, H. Zhang, S. Wu, and S. He Downregulation of protease activated receptor expression and cytokine production in p815 cells by RNA interference BMC Cell Biol 10 2009 62
34. G.J. Villares, M. Zigler, H. Wang, V.O. Melnikova, H. Wu, and R. Friedman Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNA Cancer Res 68 2008 9078 9086
35. V.O. Melnikova, K. Balasubramanian, G.J. Villares, A.S. Dobroff, M. Zigler, and H. Wang Crosstalk between protease-activated receptor 1 and platelet-activating factor receptor regulates melanoma cell adhesion molecule (mcam/muc18) expression and melanoma metastasis J Biol Chem 284 2009 28845 28855
36. J. Liu, P. Schuff-Werner, and M. Steiner Double transfection improves small interfering RNA-induced thrombin receptor (par-1) gene silencing in du 145 prostate cancer cells FEBS Lett 577 2004 175 180
37. Roger Brent, REK, J.G. Seidman, Kevin Struhl, Frederick M. Ausubel, and Virginia Benson Chanda Current protocols in molecular biology 2003 Greene Pub. Associates; J. Wiley Brooklyn, N.Y. Media, Pa order fulfillment
38. J. Sambrook, and D.W. Russell Molecular cloning: a laboratory manual 2001 Cold Spring Harbor Laboratory Press Cold Spring Harbor, N.Y.
39. T. Alsheddi, L. Vasin, R. Meduri, M. Randhawa, G. Glazko, and A. Baranova siRNAs with high specificity to the target: a systematic design by CRM algorithm Mol Biol (Mosk) 42 2008 163 171
40. A. Birmingham, E. Anderson, K. Sullivan, A. Reynolds, Q. Boese, and D. Leake A protocol for designing siRNAs with high functionality and specificity Nat Protoc 2 2007 2068 2078
41. B.R. Cullen Enhancing and confirming the specificity of RNAi experiments Nat Methods 3 2006 677 681
42. C. Dahlgren, H.Y. Zhang, Q. Du, M. Grain, G. Norstedt, and C. Wahlestedt Analysis of siRNA specificity on targets with double-nucleotide mismatches Nucleic Acids Res 36 2008 e53
43. Y. Naito, T. Yamada, K. Ui-Tei, S. Morishita, and K. Saigo Sidirect: highly effective, target-specific siRNA design software for mammalian RNA interference Nucleic Acids Res 32 2004 W124 W129